(Q40851299)

English

Clinical studies with granisetron, a new 5-HT3 receptor antagonist for the treatment of cancer chemotherapy-induced emesis. The Granisetron Study Group

scientific article

Statements

Clinical studies with granisetron, a new 5-HT3 receptor antagonist for the treatment of cancer chemotherapy-induced emesis. The Granisetron Study Group (English)
0 references
29A Suppl 1

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit